Inflammatory Bowel Disease Treatment Market

Inflammatory Bowel Disease Treatment Market Size by Type (Ulcerative Colitis, Crohn's Disease), Drug Class (Corticosteroids, Aminosalicylates, TNF inhibitors, Anti-integrin, IL inhibitors, JAK inhibitors, Others), Distribution Channel, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2030

Base Year: 2020 Historical Data: 2018-19
  • Report ID: TBI-12607
  • Published Date: Nov, 2021
  • Pages: 234
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global inflammatory bowel disease treatment market is anticipated to grow from USD 18.47 billion in 2020 to USD 28.96billion by 2030, at a CAGR of 4.6% during the forecast period 2021-2030. Over the forecast period, the increasing prevalence of Crohn's disease and ulcerative colitis around the world is anticipated to fuel market expansion. Furthermore, rising biologics adoption and the presence of promising pipeline medications like ustekinumab, upadacitinib, tofacitinib, risankizumab and others are anticipated to drive market growth in the future years.

Market Overview:

Inflammatory bowel disease (IBD) refers to two disorders (Ulcerative colitis and Crohn's disease) in which the gastrointestinal (GI) tract is inflamed for a long time. Long-term inflammation damages the gastrointestinal tract. Irritable bowel disease treatment aims to reduce the inflammation that causes your signs and symptoms. In the best-case scenario, this could result in not just symptom relief but also long-term remission and lower complications risks. Drug therapy or surgery are frequently used to treat IBD.

Colitis ulcerative: Inflammation and sores (ulcers) occur along the surface lining of your large intestine (colon) and rectum.

Crohn's disease: Inflammation of the lining of the digestive tract, which can often involve the deeper layers of the digestive tract, is an indication of this type of IBD.

Anti-inflammatory medications are frequently used as the first line of treatment against inflammatory bowel disease. Corticosteroids and aminosalicylates such mesalamine (Asacol HD, Delzicol, and others), balsalazide (Colazal), and olsalazine are anti-inflammatories (Dipentum). The type of medication to take is determined by which part of the colon is impacted.

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:
  • Rising prevalence of ulcerative colitis and Crohn’s disease

One of the primary factors projected to boost the inflammatory bowel disease treatment market is the rising prevalence of ulcerative colitis and Crohn's disease. IBD is affecting a rising number of people, fueling the demand for effective treatment alternatives.

  • Medical technology advancements

The prevalence of anxiety and sadness, as well as developments in medical technology and government support for inflammatory bowel disease treatment research, are anticipated to drive the market growth.

Restraints:
  • Higher costs

The market for inflammatory bowel disorders is predicted to grow, but it will be constrained by greater capital expenditures for drug discovery, the insufficient clinical efficacy of therapy, and strict drug regulatory policies.

Opportunities:
  • Biosimilars are getting more approval

Due to the advantages of biosimilars like Hyrimoz, Renflexis, Imraldi, and Inflectra over traditional treatment alternatives, the approval of more biosimilars is projected to enhance the adoption of effective treatment. Because emerging markets are price sensitive, the introduction of biosimilars is projected to enhance demand. Moreover, the rising approval of biosimilars for pediatric Crohn’s disease will boost market growth globally.

Challenges:
  • Covid-19 impact

The market impact of the COVID-19 pandemic was negligible in 2020, but due to the entire lockdown imposed in those countries, a decrease in the diagnosis of inflammatory bowel disease was seen in numerous countries.

Segmentation Analysis:

The global inflammatory bowel disease treatment market has been segmented based on type, drug class, distribution channel and regions.

  • The type segment is divided into ulcerative colitis, crohn's disease. The Crohn's disease segment dominated the market with around 62% in 2020. Throughout the forecast period, the segment is expected to dominate the market. Factors propelling the market for inflammatory bowel disease treatment include a high prevalence rate, rising biologic prescription rates, and the high cost of Crohn's disease treatment. According to the Crohn's and Colitis Foundation, biologics are prescribed to about 25% of Crohn's disease patients in the United States. Also, the prevalence of Crohn's disease is around 319/100,000 people in North America and 322/100,000 people in Europe, respectively.
  • The drug class segment includes corticosteroids, aminosalicylates, JAK inhibitors, TNF inhibitors, anti-integrin, IL inhibitors, others. The TNF inhibitors segment led the market with a market share around 48% in 2020. During the forecast period, the segment is expected to dominate the market. The high rate of prescription of TNF inhibitors like Remicade and Humira, as well as the efficacy of medications for IBD, are expected to boost demand during the forecast period.
  • By distribution channel, the market is segmented into retail pharmacy hospital pharmacy and online pharmacy. The hospital pharmacy segment led the market with a market share around 44% in 2020. The rising prevalence of ulcerative colitis and Crohn's disease has resulted in an increase in hospital admissions. The development of the hospital pharmacy segment in the inflammatory bowel disease treatment market is further aided by the established infrastructure of hospitals and the ease with which treatment is available.
Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America region emerged as the largest market for the Inflammatory Bowel Disease Treatment market with around 51.5% share of the market revenue in 2020.

  • Over the forecast period, the region is anticipated to grow at a lucrative rate. An increase in the prescription of novel drugs, better reimbursement policies and high treatment rates in the region are all contributing to the region's market growth.
  • With an exponential rise in the patient population, Asia-Pacific is predicted to be the fastest-growing inflammatory bowel disease treatment market. In Asia-Pacific, developing countries like Japan and China are expected to be the main markets for inflammatory bowel disease treatment. The increased prevalence of stress disorders and anxiety, as well as consumers' sedentary lifestyles, are likely to result in an increase in the patient pool, driving up the demand for treatment medications. Furthermore, during the projected period, reasonably soft drug regulatory policies and increased government activities aimed at healthcare development are expected to boost market growth.

North America Inflammatory Bowel Disease Treatment Market Share in 2020 - 51.5%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances and partnerships to improve their market position in the global inflammatory bowel disease treatment industry.

List of Key Market Players:

  • Abbott Laboratories
  • AbbVie Inc.
  • Agilent Technologies, Inc
  • Alkem Laboratories Limited
  • Allergan plc
  • B&W Tek
  • Biogen Inc.
  • CELGENE CORPORATION
  • Celltrion Healthcare
  • COSMO PHARMACEUTICALS
  • Gilead Sciences
  • Innovate Biopharmaceuticals
  • Janssen Biotech Inc.
  • Johnson & Johnson Services Inc.
  • Novartis AG
  • Pfizer Inc.
  • PG Instruments Limited
  • Takeda Pharmaceutical Company Limited
  • UCB Inc
  • Valeant Pharmaceuticals International

Key Target Audience

  • Pharmaceutical companies
  • End-users
  • Research and Development (R&D) Companies
  • Government Research Laboratories
  • Government Authorities And R&D Institutions
  • Academic & Medical Research Institutions
  • Investors

Report Description:

  • Global Inflammatory Bowel Disease Treatment Market, Industry Analysis, Trends, Analysis and Forecast, 2021 to 2030 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2020 is considered as the base year of the report. 2018 and 2019 are considered as the historic years and 2021 to 2030 are the forecast years. The global inflammatory bowel disease treatment market is based on revenue (USD Billion). The report incorporates the market study on the basis of revenue, and volume. The study covers the market share revenue/market share for each of the segments, regions and countries catering to global Inflammatory Bowel Disease Treatment market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America and Middle East &Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts all across the globe. The research report also delivers an outline of the attractiveness of inflammatory bowel disease treatment on the basis of type, drug class, distribution channel and regions which are deduced and formulated on the basis of their growth rate (CAGR), market size, and attractiveness by analyzing the present and future prospects to fathom market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global Inflammatory Bowel Disease Treatment market. This offers vital and in depth insights in order to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global inflammatory bowel disease treatment market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario.
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis so as to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development in order to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which acts as a key potential for the investors.
  • Potential growth prospects along with the penetration rate analysis of the products (market related i.e., global Inflammatory Bowel Disease Treatment market) is covered in order to comprehend the adoption rate and evaluate the market size.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the inflammatory bowel disease treatment market was valued at USD 18.47 billion in 2020 to USD 28.96 billion by 2030.

Global inflammatory bowel disease treatment market is growing at a CAGR of 4.6% during the forecast period 2021-2030.

The global inflammatory bowel disease treatment market has been segmented based on type, drug class, distribution channel and regions. The crohn's disease segment dominated the type segment in the market in 2020.

The North America region emerged as the largest market for the inflammatory bowel disease treatment.

Rising prevalence of ulcerative colitis and Crohn’s disease is the key driving factor for the inflammatory bowel disease treatment market.

Biosimilars are getting more approval which will provide huge opportunities to the market.

Key players are Abbott Laboratories, AbbVie Inc., Agilent Technologies, Inc, Alkem Laboratories Limited, Allergan plc, B&W Tek, Biogen Inc., CELGENE CORPORATION, Celltrion Healthcare, COSMO PHARMACEUTICALS

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis ByType
          4.3.2. Market Attractiveness Analysis ByDrug class
          4.3.3. Market Attractiveness Analysis ByDistribution channel
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rising prevalence of ulcerative colitis and Crohn’s disease
          5.2.2. Medical technology advancements
    5.3. Restraints
          5.3.1. Higher costs
    5.4. Opportunities
          5.4.1. Biosimilars are getting more approval
    5.5. Challenges
          5.5.1. Covid-19 impact

6. Global Inflammatory bowel disease treatment Market Analysis and Forecast, By Type
    6.1. Segment Overview
    6.2. Ulcerative Colitis
    6.3. Crohn’s Disease

7. Global Inflammatory bowel disease treatment Market Analysis and Forecast, By Drug class
    7.1. Segment Overview
    7.2. Corticosteroids
    7.3. Aminosalicylates
    7.4. TNF inhibitors
    7.5. Anti-integrin
    7.6. IL inhibitors
    7.7. JAK inhibitors
    7.8. Others

8. Global Inflammatory bowel disease treatment MarketAnalysis and Forecast, By Distribution channel
    8.1. Segment Overview
    8.2. Retail pharmacy
    8.3. Hospital pharmacy
    8.4. Online pharmacy

9. Global Inflammatory bowel disease treatment MarketAnalysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Inflammatory bowel disease treatment Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in GlobalInflammatory bowel disease treatment Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Abbott Laboratories
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. AbbVie Inc.
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Agilent Technologies, Inc.
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Alkem Laboratories Limited
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Allergan plc
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. B&W Tek
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Biogen Inc.
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Celgene Corporation
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Celltrion Healthcare
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Cosmo Pharmaceuticals
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
    11.11. Gilead Sciences
          11.11.1. Business Overview
          11.11.2. Company Snapshot
          11.11.3. Company Market Share Analysis
          11.11.4. Company Product Portfolio
          11.11.5. Recent Developments
          11.11.6. SWOT Analysis
    11.12. Innovate Biopharmaceuticals
          11.12.1. Business Overview
          11.12.2. Company Snapshot
          11.12.3. Company Market Share Analysis
          11.12.4. Company Product Portfolio
          11.12.5. Recent Developments
          11.12.6. SWOT Analysis
    11.13. Janssen Biotech Inc.
          11.13.1. Business Overview
          11.13.2. Company Snapshot
          11.13.3. Company Market Share Analysis
          11.13.4. Company Product Portfolio
          11.13.5. Recent Developments
          11.13.6. SWOT Analysis
    11.14. Johnson & Johnson Services Inc.
          11.14.1. Business Overview
          11.14.2. Company Snapshot
          11.14.3. Company Market Share Analysis
          11.14.4. Company Product Portfolio
          11.14.5. Recent Developments
          11.14.6. SWOT Analysis
    11.15. Novartis AG
          11.15.1. Business Overview
          11.15.2. Company Snapshot
          11.15.3. Company Market Share Analysis
          11.15.4. Company Product Portfolio
          11.15.5. Recent Developments
          11.15.6. SWOT Analysis
    11.16. Pfizer Inc.
          11.16.1. Business Overview
          11.16.2. Company Snapshot
          11.16.3. Company Market Share Analysis
          11.16.4. Company Product Portfolio
          11.16.5. Recent Developments
          11.16.6. SWOT Analysis
    11.17. PG Instruments Limited
          11.17.1. Business Overview
          11.17.2. Company Snapshot
          11.17.3. Company Market Share Analysis
          11.17.4. Company Product Portfolio
          11.17.5. Recent Developments
          11.17.6. SWOT Analysis
    11.18. Takeda Pharmaceutical Company Limited
          11.18.1. Business Overview
          11.18.2. Company Snapshot
          11.18.3. Company Market Share Analysis
          11.18.4. Company Product Portfolio
          11.18.5. Recent Developments
          11.18.6. SWOT Analysis
    11.19. UCB Inc
          11.19.1. Business Overview
          11.19.2. Company Snapshot
          11.19.3. Company Market Share Analysis
          11.19.4. Company Product Portfolio
          11.19.5. Recent Developments
          11.19.6. SWOT Analysis
    11.20. Valeant Pharmaceuticals International
          11.20.1. Business Overview
          11.20.2. Company Snapshot
          11.20.3. Company Market Share Analysis
          11.20.4. Company Product Portfolio
          11.20.5. Recent Developments
          11.20.6. SWOT Analysis
 

List of Table

1.Global Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

2.Global Ulcerative Colitis Inflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

3.Global Crohn’s Disease Inflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

4.Global Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

5.Global CorticosteroidsInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

6.Global Aminosalicylates, Inflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

7.Global TNF inhibitorsInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

8.Global Anti-integrinInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

9.Global IL inhibitorsInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

10.Global JAK inhibitorsInflammatory bowel disease treatment Market, By Region, 2018–2030  (USD Billion)

11.Global Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

12.GlobalRetail pharmacyInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

13.Global Hospital pharmacyInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

14.Global Online pharmacyInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

15.Global Inflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

16.Global Inflammatory bowel disease treatment Market, By North America, 2018–2030 (USD Billion)

17.North America Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

18.North America Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

19.North America Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

20.U.S. Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

21.U.S. Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

22.U.S. Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

23.Canada Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

24.Canada Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

25.Canada Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

26.Mexico Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

27.Mexico Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

28.Mexico Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

29.Europe Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

30.Europe Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

31.Europe Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

32.Germany Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

33.Germany Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

34.Germany Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

35.France Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

36.France Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

37.France Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

38.U.K. Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

39.U.K. Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

40.U.K. Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

41.Italy Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

42.Italy Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

43.Italy Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

44.Spain Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

45.Spain Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

46.Spain Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

47.Asia Pacific Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

48.Asia Pacific Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

49.Asia Pacific Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

50.Japan Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

51.Japan Inflammatory bowel disease treatment Market, By Drug clas,2018–2030 (USD Billion)

52.Japan Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

53.China Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

54.China Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

55.China Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

56.India Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

57.India Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

58.India Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

59.South America Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

60.South America Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

61.South America Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

62.Brazil Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

63.Brazil Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

64.Brazil Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

65.Middle East and Africa Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

66.Middle East and Africa Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

67.Middle East and Africa Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

68.UAE Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

69.UAE Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

70.UAE Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

71.South Africa Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

72.South Africa Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

73.South Africa Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

 

List of Figures 

1. Global Inflammatory bowel disease treatment market segmentation

2. Inflammatory bowel disease treatment Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis

7. Value Chain Analysis

8. Global Inflammatory bowel disease treatment MarketAttractiveness Analysis ByType

9. Global Inflammatory bowel disease treatment MarketAttractiveness Analysis ByDrug class

10. Global Inflammatory bowel disease treatment MarketAttractiveness Analysis ByDistribution channel

11. Global Inflammatory bowel disease treatment MarketAttractiveness Analysis By Region

12. Global Inflammatory bowel disease treatment Market: Dynamics

13.Global Inflammatory bowel disease treatment MarketShare ByType (2021 & 2030)

14. Global Inflammatory bowel disease treatment MarketShare By Drug class (2021 & 2030)

15. Global Inflammatory bowel disease treatment MarketShare By Distribution channel(2021 & 2030)

16. Global Inflammatory bowel disease treatment MarketShare by Regions (2021 & 2030)

17.Global Inflammatory bowel disease treatment MarketShare by Company (2020)

This study forecasts revenue at global, regional, and country levels from 2018 to 2030. The Brainy Insights has segmented the global Inflammatory Bowel Disease Treatment market on the basis of below-mentioned segments:

Global Inflammatory Bowel Disease Treatment Market by Type:

  • Ulcerative Colitis
  • Crohn's Disease

Global Inflammatory Bowel Disease Treatment Market by Drug Class:

  • Corticosteroids
  • Aminosalicylates
  • TNF inhibitors
  • Anti-integrin
  • IL inhibitors
  • JAK inhibitors
  • Others

Global Inflammatory Bowel Disease Treatment Market by distribution Channel:

  • Retail pharmacy
  • Hospital pharmacy
  • Online pharmacy

Global Inflammatory Bowel Disease Treatment Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date